Ezetimibe is in a new class of lipid-lowering compounds (cholesterol absorption inhibitor) - it selectively inhibits the intestinal absorption of cholesterol and related plant sterols. Some features of this agent are described:
Notes:
The summary of product characteristics should be consulted before prescribing this drug.
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page